Clinical Trial Update: Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating selective estrogen receptor modulators for women of child-bearing age with schizophrenia or schizoaffective disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: The Alfred | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED